Time-dependent glycemic variability and mortality in critically ill patients with diabetes

Critical Care Medicine

Volumn 39, Issue 1, 2011, Pages 211-213

  Umpierrez, Guillermo E ^a   Smiley, Dawn ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

glucose variability; hospital hyperglycemia; inpatient hyperglycemia; type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; EDITORIAL; GLUCOSE BLOOD LEVEL; HEART SURGERY; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE UNIT; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EID: 78651240262     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318202e7c0     Document Type: Editorial

References (30)

1. Falciglia M, Freyberg RW, Almenoff PL, et al: Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 2009;37:3001-3009
2. Umpierrez GE, Isaacs SD, Bazargan N, et al: Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87:978-982
3. Krinsley JS: Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003;78:1471-1478
4. Furnary AP, Zerr KJ, Grunkemeier GL, et al: Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999;67:352-360;discussion 360-362
5. Furnary AP, Gao G, Grunkemeier GL, et al: Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003;125:1007-1021
6. van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345: 1359-1367
7. Frisch A, Chandra P, Smiley D, et al: Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care 2010;33:1783-1788
8. Clement S, Braithwaite SS, Magee MF, et al: Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004;27:553-597
9. Brunkhorst FM, Engel C, Bloos F, et al: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-139
10. Finfer S, Chittock DR, Su SY, et al: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360: 1283-1297
11. Griesdale DE, de Souza RJ, van Dam RM, et al: Intensive insulin therapy and mortality among critically ill patients: A meta-analysis including NICE-SUGAR study data. CMAJ 2009;180:821-827
12. Edwards FH, Grover FL, Shroyer AL, et al: The Society of Thoracic Surgeons National Cardiac Surgery Database: Current risk assessment. Ann Thorac Surg 1997;63: 903-908
13. Bagdade JD, Root RK, Bulger RJ: Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 1974;23:9-15
14. Iwasaki Y, Kambayashi M, Asai M, et al: High glucose alone, as well as in combination with proinflammatory cytokines, stimulates nuclear factor kappa-B-mediated transcription in hepatocytes in vitro. J Diabetes Complications 2007;21:56-62
15. Stegenga ME, van der Crabben SN, Dessing MC, et al: Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabet Med 2008;25:157-164
16. Mohanty P, Hamouda W, Garg R, et al: Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 2000;85:2970-2973
17. Garg R, Chaudhuri A, Munschauer F, et al: Hyperglycemia, insulin, and acute ischemic stroke: A mechanistic justification for a trial of insulin infusion therapy. Stroke 2006;37: 267-273
18. Krinsley JS: Glycemic variability: A strong independent predictor of mortality in critically ill patients. Crit Care Med 2008;36: 3008-3013
19. Ceriello A, Ihnat MA. 'Glycaemic variability': A new therapeutic challenge in diabetes and the critical care setting. Diabet Med 2010;27:862-867
20. Kilpatrick ES, Rigby AS, Atkin SL: A1C variability and the risk of microvascular complications in type 1 diabetes: Data from the Diabetes Control and Complications Trial. Diabetes Care 2008;31:2198-2202
21. Nishikawa T, Edelstein D, Du XL, et al: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404: 787-790
22. Siegelaar SE, Holleman F, Hoekstra JB, et al: Glucose variability;does it matter? Endocr Rev 31:171-182
23. Ceriello A, Esposito K, Piconi L, et al: Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008;57: 1349-1354
24. Buscemi S, Verga S, Cottone S, et al: Glycaemic variability and inflammation in subjects with metabolic syndrome. Acta Diabetol 2009;46:55-61
25. Dossett LA, Cao H, Mowery NT, et al: Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg 2008;74:679-685;discussion 685
26. Monnier L, Colette C, Leiter L, et al: The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 2007;30:185-186;author reply 187-188
27. Goyal A, Mahaffey KW, Garg J, et al: Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: Results from the CARDINAL study. Eur Heart J 2006;27:1289-1297
28. Egi M, Bellomo R, Stachowski E, et al: The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med 2011;39:105-111
29. Finney SJ, Zekveld C, Elia A, et al: Glucose control and mortality in critically ill patients. JAMA 2003;290:2041-2047
30. Moghissi ES, Korytkowski MT, DiNardo M, et al: American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009;32:1119-1131